• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rediscovering Brazil: How We Prevent and Treat Cardiovascular Disease.重新认识巴西：我们如何预防和治疗心血管疾病。
Arq Bras Cardiol. 2021 Jan;116(1):117-118. doi: 10.36660/abc.20201295.
2
Targeted pharmacotherapy for cardiovascular risk reduction in patients with diabetes undergoing liver transplantation.针对接受肝移植的糖尿病患者进行心血管风险降低的靶向药物治疗。
Eur J Intern Med. 2020 Oct;80:104. doi: 10.1016/j.ejim.2020.07.018. Epub 2020 Jul 22.
3
Targeted pharmacotherapy for cardiovascular risk reduction in patients with diabetes undergoing liver transplantation: Author's reply.肝移植糖尿病患者降低心血管风险的靶向药物治疗：作者回复
Eur J Intern Med. 2020 Oct;80:105. doi: 10.1016/j.ejim.2020.08.003. Epub 2020 Aug 5.
4
"Know the Enemy and Know Yourself". Cardiovascular Risk in the National Health Survey.“知己知彼”。国民健康调查中的心血管风险。
Arq Bras Cardiol. 2021 Mar;116(3):432-433. doi: 10.36660/abc.20210105.
5
Letter to the Editor: "Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry".致编辑的信：“1型糖尿病成人患者心血管疾病（CVD）的危险因素：来自前瞻性真实生活T1D交换登记处的发现”
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa383.
6
Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?心血管疾病中度风险个体的低密度脂蛋白胆固醇降低：降低百分比还是目标水平？
Clin Cardiol. 2018 Mar;41(3):333-338. doi: 10.1002/clc.22868. Epub 2018 Mar 25.
7
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.ω-3脂肪酸对心血管高危患者主要心血管事件的影响
JAMA. 2021 Apr 6;325(13):1333. doi: 10.1001/jama.2021.0821.
8
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.ω-3脂肪酸对心血管高危患者主要心血管事件的影响。
JAMA. 2021 Apr 6;325(13):1332-1333. doi: 10.1001/jama.2021.0824.
9
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.ω-3脂肪酸对心血管高危患者主要心血管事件的影响。
JAMA. 2021 Apr 6;325(13):1334. doi: 10.1001/jama.2021.0827.
10
Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.ω-3脂肪酸对心血管高危患者主要心血管事件的影响。
JAMA. 2021 Apr 6;325(13):1333. doi: 10.1001/jama.2021.0830.

本文引用的文献

1
Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT).高心血管风险患者临床实践登记处（REACT）患者 1 年随访评估。
Arq Bras Cardiol. 2021 Jan;116(1):108-116. doi: 10.36660/abc.20190885.
2
Cardiovascular Statistics - Brazil 2020.心血管统计数据 - 巴西2020年
Arq Bras Cardiol. 2020 Sep;115(3):308-439. doi: 10.36660/abc.20200812.
3
Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.冠状动脉旁路移植术与经皮冠状动脉介入治疗：药物治疗至关重要：药物治疗依从性对比较结果的影响。
Circulation. 2016 Oct 25;134(17):1238-1246. doi: 10.1161/CIRCULATIONAHA.115.021183.
4
Cardiovascular Health in Brazil: Trends and Perspectives.巴西的心血管健康：趋势与展望。
Circulation. 2016 Jan 26;133(4):422-33. doi: 10.1161/CIRCULATIONAHA.114.008727.
5
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.最优药物治疗可改善经皮冠状动脉介入治疗或冠状动脉旁路移植术血运重建患者的临床结局：来自经皮冠状动脉介入治疗与紫杉醇洗脱支架和心脏手术（SYNTAX）试验的 5 年随访结果。
Circulation. 2015 Apr 7;131(14):1269-77. doi: 10.1161/CIRCULATIONAHA.114.013042. Epub 2015 Feb 24.
6
Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.冠状动脉疾病的手术、血管成形术或药物治疗的成本效益分析：药物、血管成形术或手术研究（MASS）II 试验的 5 年随访。
Circulation. 2012 Sep 11;126(11 Suppl 1):S145-50. doi: 10.1161/CIRCULATIONAHA.111.084442.

Rediscovering Brazil: How We Prevent and Treat Cardiovascular Disease.

作者信息

Costa Letícia Rodrigues, Passos Eduardo Vasconcelos, Silvestre Odilson Marcos

机构信息

Universidade Federal do Acre, Rio Branco, AC - Brasil.

出版信息

Arq Bras Cardiol. 2021 Jan;116(1):117-118. doi: 10.36660/abc.20201295.

DOI:10.36660/abc.20201295
PMID:33566974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159489/
Abstract
摘要